An informative video interview with Professor Steve Conlan of the College of Medicine at Swansea University (UK) highlights the latest research developments in women’s reproductive health using unique molecular biology tools.

Developed by Prof Conlan in conjunction with Porvair Sciences, the Chromatrap solid state ChIP assay enables more tissue biopsies to be profiled for epigenetic landscape in less time and with greater efficiency than previously possible. Prof Conlan explains the aims of his group’s work towards regenerative and personalised medicine therapies for the treatment of common gynaecological conditions such as ovarian and endometrial cancers and the role that the new Chromatrap ChIP assay tool has played in allowing faster progress in this research area.

A further video interview with Steve Knight of Porvair Sciences demonstrates the utility of the ChromaTrap solid state ChIP assay which enables high quality chromatin to be obtained from as few as 7000 cells in under five hours. Laborious and error-prone liquid handling steps associated with traditional methods are eliminated with this novel filter-based kit.

Established in 1992, Porvair Sciences Ltd. has developed internationally recognised expertise in microplate technology and manufacturing serving applications in Drug Discovery, Combinatorial Chemistry, Solid Phase Extraction, Protein Purification, High Throughput Screening, Environmental Analysis, Proteomics and Genomics. Porvair Sciences Ltd. is a wholly owned subsidiary of Porvair plc.

more about porvair sciences

more news from porvair sciences